Author

T. Shien

Feasibility Study of Docetaxel with Cyclophosphamide as Adjuvant Chemotherapy for Japanese Breast Cancer Patients

2009 · D. Takabatake, N. Taira, et al. · Japanese Journal of Clinical Oncology · 41

Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrence

2015 · Y. Okumura, R. Nishimura, et al. · European Journal of Surgical Oncology · 16

Abstract P4-05-09: Estrogen receptor (ER) mRNA expression and molecular subtype distribution in breast cancers that are ER-negative but progesterone receptor-positive by immunohistochemistory

2013 · T Iwamoto, J Matsuoka, et al. · Cancer Research · 5

Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective study

2025 · Y. Ozaki, E. Tokuda, et al. · ESMO Open · 2

PDF

160TiP A randomized controlled phase III study of bevacizumab and paclitaxel in combination with atezolizumab as a treatment for patients with locally advanced or metastatic hormone receptor-positive HER2-negative breast cancer: JCOG1919E/AMBITION study

2022 · F. Hara, M. Ono, et al. · Annals of Oncology · 2

The current multidisciplinary approach to fertility preservation for breast cancer patients

2017 · Y. Takahashi, T. Shien, et al. · The Breast · 1

PDF

318P Effect of local symptom suppression by primary tumor resection for de-novo stage IV breast cancer

2025 · T. Shien, M. Ishitobi, et al. · ESMO Open

PDF

156P Clinical complete response rate and predictive factors in HER2-positive early breast cancer treated with primary systemic therapy aiming for non-surgical therapy: An exploratory analysis of JCOG1806

2025 · H. Shigematsu, T. Fujisawa, et al. · ESMO Open

PDF

P232: Neoadjuvant chemotherapy response in breast cancer patients with germline BRCA pathogenic variants

2025 · A. Mimata, Y. Takahashi, et al. · The Breast

P025: Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efcacy, and Cost Efectiveness

2025 · T. Mamori, M. Tanioka, et al. · The Breast

O18-2 Second interim analysis of REIWA study (JBCRG-C07), observational study of gene panel testing in metastatic breast cancer

2024 · H. Tada, H. Masuda, et al. · Annals of Oncology

PDF

MO63-2 Clinical practice of oncotype DX in our institute: a comparative analysis of cases before and after approval

2024 · T. Mamori, T. Shien, et al. · Annals of Oncology

305P Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: A retrospective multi-institutional study

2024 · H. Seki, A. Ogiya, et al. · Annals of Oncology

PDF

411P Interim analysis of prospective observational study to evaluate the impact of cancer gene panel tests on treatment decision making in metastatic or recurrent breast cancer in Japan: JBCRG-C07 REIWA study

2024 · H. Masuda, M. Hattori, et al. · Annals of Oncology

PDF

176P The effectiveness of long-term physical activity after exercise and educational programs on breast cancer-related lymphoedema: Secondary analyses from a randomized controlled trial: The Setouchi Breast Project 10

2022 · S. Nakamoto, N. Taira, et al. · Annals of Oncology

PDF

Abstract OT3-07-02: Influence of exercise or educational programs on long-term physical activity by patients after surgery for primary breast cancer: A randomized trial

2017 · K Kawada, N Taira, et al. · Cancer Research

P312 Influence of immediate breast reconstruction (IBR) on adjuvant therapy for breast cancer patients

2015 · T. Nogami, N. Taira, et al. · The Breast

Abstract P3-07-10: Breast cancer risk-related gene polymorphisms, ESR1/6q25.1-rs2046210 and rs3757318, and clinical characteristics of breast cancer patients

2013 · N Taira, T Mizoo, et al. · Cancer Research

Abstract P2-01-07: Analysis of the relationship between breast cancer risk-related gene polymorphisms, ESR1/6q25.1-rs2046210 and mammographic breast density

2013 · T Nogami, N Taira, et al. · Cancer Research

P5-23-02: Clinicopathological Features of Young Patients Age <35 Years with Breast Cancer in Japan.

2011 · A Kataoka, E Tokunaga, et al. · Cancer Research

P183 Prognostic impact of discordance of biological markers between primary and metastatic breast cancer tissue from autopsy

2011 · T. Nogami, T. Shien, et al. · The Breast

PDF

Abstract P5-14-20: Clinical Features of Surgical Resection for Solitary Pulmonary Metastasis and the Discrepancy in Immunopathological Features between Primary and Metastatic Breast Cancer Lesions

2010 · T Shien, T Nogami, et al. · Cancer Research

Works count: 22

Citation count: 67

H-index: 3

I10-index: 2